Potential involvement of dietary advanced glycation end products in impairment of skeletal muscle growth and muscle contractile function in mice

Br J Nutr. 2017 Jan;117(1):21-29. doi: 10.1017/S0007114516004591. Epub 2017 Jan 17.

Abstract

Diets enriched with advanced glycation end products (AGE) have recently been related to muscle dysfunction processes. However, it remains unclear whether long-term exposure to an AGE-enriched diet impacts physiological characteristics of skeletal muscles. Therefore, we explored the differences in skeletal muscle mass, contractile function and molecular responses between mice receiving a diet high in AGE (H-AGE) and low in AGE (L-AGE) for 16 weeks. There were no significant differences between L-AGE and H-AGE mice with regard to body weight, food intake or epididymal fat pad weight. However, extensor digitorum longus (EDL) and plantaris (PLA) muscle weights in H-AGE mice were lower compared with L-AGE mice. Higher levels of N ε -(carboxymethyl)-l-lysine, a marker for AGE, in EDL muscles of H-AGE mice were observed compared with L-AGE mice. H-AGE mice showed lower muscle strength and endurance in vivo and lower muscle force production of PLA muscle in vitro. mRNA expression levels of myogenic factors including myogenic factor 5 and myogenic differentiation in EDL muscle were lower in H-AGE mice compared with L-AGE mice. The phosphorylation status of 70-kDa ribosomal protein S6 kinase Thr389, an indicator of protein synthesis signalling, was lower in EDL muscle of H-AGE mice than that of L-AGE mice. These findings suggest that long-term exposure to an AGE-enriched diet impairs skeletal muscle growth and muscle contractile function, and that these muscle dysfunctions may be attributed to the inhibition of myogenic potential and protein synthesis.

Keywords: AGE advanced glycation end products; CML N ∑-(carboxymethyl)-L-lysine; EDL extensor digitorum longus; H-AGE high in AGE; L-AGE low in AGE; LC3 microtubule-associated protein light-chain 3; MHC myosin heavy chain; Myf5 myogenic factor 5; MyoD myogenic differentiation; PLA plantaris; Pax7 paired box 7; SOL soleus; mTOR mammalian target of rapamycin; p70S6K 70-kDa ribosomal protein S6 kinase; Muscle fatigue resistance; Muscle force production; Muscle strength; Myogenesis; Protein synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animal Feed
  • Animal Nutritional Physiological Phenomena
  • Animals
  • Diet
  • Gene Expression Regulation / drug effects
  • Glycation End Products, Advanced / administration & dosage*
  • Glycation End Products, Advanced / toxicity
  • Lysine / analogs & derivatives
  • Lysine / metabolism
  • Male
  • Mice
  • Mice, Inbred ICR
  • Muscle Contraction / drug effects*
  • Muscle, Skeletal / growth & development*
  • Myogenic Regulatory Factors / genetics
  • Myogenic Regulatory Factors / metabolism
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism

Substances

  • Glycation End Products, Advanced
  • Myogenic Regulatory Factors
  • RNA, Messenger
  • N(6)-carboxymethyllysine
  • Lysine